What does Isomorphic Labs do?
Isomorphic Labs is an AI-first drug design and development company that uses foundational AI models to work across various therapeutic areas and drug modalities. They continually innovate on model architecture to advance drug design.
How much did they raise?
The company raised $600M in a funding round led by Thrive Capital with participation from GV and Alphabet, marking a significant investment into its AI research and development efforts.
What are their plans for the money?
The funds will be used to accelerate its AI research, enhance its drug design engine, and expand its team, potentially driving faster and more innovative developments in the pharmaceutical industry.
What have they achieved so far?
Isomorphic Labs has already built a robust AI drug design engine and is actively innovating on model architecture, demonstrating its progress in developing cutting-edge AI capabilities for drug discovery.
